Contact

Secretary´s office:

Competence network
"TDM KJP e.V."
Kristina Münkel
Clinic for child and youth psychiatry/ psychotherapy University of Ulm
Steinhövelstr. 5
89075 Ulm


Tel.: (+49) 0731-500-61604
Email: kristina.muenkel@uniklinik-ulm.de

Financial Support

The German Ministry for Education and Science (Bundesministerium für Bildung und Forschung BMBF) financially supports the Competence Network TDM KJP within its programme for the development of new instruments and methods for patient-oriented medical research.
Title of the project: "Therapeutic Drug Monitoring in child and adolescent psychiatry. Competence network and patient registry for psychopharmacological research: establishment and further development of a multicentre IT-infrastructure."

Bundesministerium für Bildung und Forschung

Society for "Durchführung Neurowissenschaftlicher Tagungen e.V.", Paulsborner-Strasse 44, 14193 Berlin



Publications

Klampfl K, Taurines R, Preuss A, Burger R, Rothenhöfer S, Wewetzer Ch, Pfuhlmann B, Fegert J, Gerlach M, Mehler-Wex C (2010):
Serum concentrations, therapeutic response and side effects in children and adolescents with impulsive-aggressive symptoms during risperidone therapy.
Pharmacopsychiatry. 2010 Mar;43(2):58-65. Epub 2009 Dec 10

Baumann P, Hiemke C, Ulrich S, Eckermann G, Gaertner I, Gerlach M, Kuss HJ, Laux G, Müller-Oerlinghausen B, Rao ML, Riederer P, Zernig G: The AGNP-TDM expert group consensus guidelines: Therapeutic drug monitoring in Psychiatry. Pharmacopsychiatry 37:243-265, 2004.

Gerlach M, Klampfl K, Mehler-Wex C, Warnke A: Besonderheiten der Neuro-Psychopharmakologie im Kindes- und Jugendalter. In: Gerlach M. Mehler-Wex C, Walitza S, Warnke A Wewetzer Ch (Hrsg.) Neuro-Psychopharmaka im Kindes- und Jugendalter. Grundlagen und Therapie. Wien, New York, Springer, in press.

Gerlach M, Rothenhöfer S, Mehler-Wex C, Fegert JM, Schulz E, Wewetzer Ch, Warnke A (2006) Therapeutisches Drug-Monitoring in der Kinder- und Jugend­psychiatrie – Grundlagen und praktische Empfehlungen. Z Kinder-Jugendpsychiatr 34: 5-13

Gerlach M, Hünnerkopf R, Rothenhöfer S, Libal G, Burger R, Clement H-W, Fegert JM, Wewetzer Ch, Mehler-Wex C: Therapeutic drug monitoring of quetiapine in adolescents with psychotic disorders. Pharmacopsychiatry 40:72-76, 2007.

Gerlach M, Rothenhöfer S, Mehler-Wex C, Baumann P, Hiemke Ch, Eckermann G, Gärtner I, Kuss HJ, Laux G, Müller-Oerlinghausen B, Rao ML, Riederer P, Ulrich S, Zernig G, Wewetzer Ch: Therapeutisches Drug Monitoring in der Kinder- und Jugendpsychiatrie. Psychopharmakotherapie 4:118-120, 2005.

Kirchheiner, J, J Brockmoller (2005) "Clinical consequences of cytochrome P450 2C9 polymorphisms." Clin Pharmacol Ther 77(1): 1-16.

Kirchheiner, J, K Brøsen, ML Dahl, LF Gram, S Kasper, I Roots, F Sjoqvist, E Spina, J Brockmöller (2001) "CYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants: a first step towards subpopulation-specific dosages." Acta Psychiatr Scand 104(3): 173-192.